Progress in tuberculosis vaccine development and host-directed therapies—a 
state of the art review

Kaufmann, Stefan H. E.; Lange, Christoph; Rao, Martin; Balaji, Kithiganahalli N; Lotze, Michael; Schito, Marco; Zumla, Alimuddin I; Maeurer, Markus

doi:10.1016/S2213-2600(14)70033-5

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review

MPS-Authors

/persons/resource/persons81969

Kaufmann, Stefan H. E.
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Kaufmann, S. H. E., Lange, C., Rao, M., Balaji, K. N., Lotze, M., Schito, M., Zumla, A. I., & Maeurer, M. (2014). Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review. The Lancet Respiratory Medicine, 2(4), 301-320. doi:10.1016/S2213-2600(14)70033-5.

引用: https://hdl.handle.net/11858/00-001M-0000-001A-11DA-A

要旨

要旨はありません